Search results
Results from the WOW.Com Content Network
Beginning in 2011, a contraceptive product based on RISUG, Vasalgel, was under development in the US by the Parsemus Foundation, who were unable to bring the product to market over the next decade. [3] In 2023, the patent for Vasalgel was acquired by NEXT Life Sciences, which plans to bring the technology to market under the name Plan A for Men ...
Founded in 2005, Parsemus is an advocate of research into the plausibility of RISUG (and a method based on RISUG, called Vasalgel), a reversible male contraceptive. [2] [3] The foundation began procuring RISUG's United States intellectual property rights in November 2010, completed the acquisition process in February 2012, and is for the past 8 years conducting toxicology tests as an initial ...
Vasalgel was successful in achieving azoospermia in rabbits within 36 days of injection, as well as returned vas deferens patency. [9] In 2023, the patent for Vasalgel was acquired by NEXT Life Sciences , Inc., which plans to bring the technology to market under the name Plan A for Men .
Yet, investors are overlooking this guidance as the stock is performing well today. Other stocks rising in the Dow include Caterpillar, Boeing, Home Depot, and UnitedHealth.
Indexes edged slightly higher as traders took a breather after the huge post-election rally. The Fed will deliver its next rate decision at 2 p.m.
NEW YORK (AP) — U.S. stock indexes closed their best week in two months with a flourish on Friday. The S&P 500 climbed 1% to clinch its first winning week in the last three.The Dow Jones ...
U.S. stocks rose Tuesday after more companies said they made bigger profits at the end of last year than analysts expected and as Treasury yields eased. The S&P 500 climbed 0.9%, while many ...
U.S. stocks rose Monday as Wall Street took President Donald Trump’s latest threat on tariffs in stride. The S&P 500 climbed 0.7%, coming off a losing week that was bookended by worries about ...